Evidence map›Paper›PMID 25593470›Full record

ArticleWorld journal of gastroenterology2015

Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.

Nozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nozomi KamijoNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Akihiro MatsumotoNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Takeji UmemuraNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Soichiro ShibataNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Yuki IchikawaNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Takefumi KimuraNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Michiharu KomatsuNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Eiji TanakaNozomi Kamijo, Akihiro Matsumoto, Takeji Umemura, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Eiji Tanaka, Department of Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the role of pre-core and basal core promoter (BCP) mutations before and after hepatitis B e antigen (HBeAg) seroconversion.

methodsThe proportion of pre-core (G1896A) and basal core promoter (A1762T and G1764A) mutant viruses and serum levels of hepatitis B virus (HBV) DNA, hepatitis B surface antigen (HBsAg), and HB core-related antigen were analyzed in chronic hepatitis B patients before and after HBeAg seroconversion (n = 25), in those who were persistently HBeAg positive (n = 18), and in those who were persistently anti-HBe positive (n = 43). All patients were infected with HBV genotype C and were followed for a median of 9 years.

resultsAlthough the pre-core mutant became predominant (24% to 65%, P = 0.022) in the HBeAg seroconversion group during follow-up, the proportion of the basal core promoter mutation did not change. Median HBV viral markers were significantly higher in patients without the mutations in an HBeAg positive status (HBV DNA: P = 0.003; HBsAg: P < 0.001; HB core-related antigen: P = 0.001). In contrast, HBV DNA (P = 0.012) and HBsAg (P = 0.041) levels were significantly higher in patients with the pre-core mutation in an anti-HBe positive status.

conclusionThere is an opposite association of the pre-core mutation with viral load before and after HBeAg seroconversion in patients with HBV infection.

Indexed as

MutationPromoter Regions, GeneticAdultAgedDNA, ViralFemaleGenetic Predisposition to DiseaseGenotypeHepatitis B, ChronicHepatitis B Core AntigensHepatitis B e AntigensHepatitis B virusHumansMaleMiddle AgedPhenotypeDNA, ViralHepatitis B Core AntigensHepatitis B e AntigensViral Core ProteinsBasal core promoterHepatitis B core-related antigenHepatitis B surface antigenHepatitis B virus DNAMutationPre-coreSeroconversion

Identifiers

PMID25593470
PMCPMC4292286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.